Nonalcoholic steatohepatitis will pose clinical, economic burden
Nonalcoholic steatohepatitis (NASH) is expected to pose a significant clinical and economic burden during the next 20 years for U.S. patients with type 2 diabetes mellitus (T2DM), according to a study published online Jan. ...
Jan 15, 2020
0
2